1 Product identity
Ingredient risk
1 ingredient to use with caution
BromeZyme
BrandKaruna→Non-Nutrient/Non-Botanical Tablet or Pill 5 ingredients 1 caution DSLD #23868Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-08-23
2 Ingredients (5)
IngredientGroupSafety
CelluloseCellulose—
Stearic AcidStearic Acid—
DextroseGlucose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Bromelain — Conditionally Safe
⚠ Increased bleeding risk
⚠ GI upset
Magnesium — Use with Caution
4 Label claims
• All Other
5 Data source
DSLD ID23868
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-08-23
6 More from Karuna
View Karuna Safety Scorecard → 86 products
5-HTP 100 mg5-HTP 100 mgAllerEzeAlpha Lipoic Acid 100 mgB-12 LiquidBromeZyme 24007 Cite this page
Vancouver
Pkhakadze G. BromeZyme — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 20]. Available from: https://supplement.ge/products/bromezyme-23868/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG